Skip to main content
. Author manuscript; available in PMC: 2013 Apr 15.
Published in final edited form as: Clin Cancer Res. 2012 Feb 20;18(8):2278–2289. doi: 10.1158/1078-0432.CCR-11-1593

Table 1.

EDRN Cohort Subject and Disease Characteristics

All Cases TMA Cases RPPA Cases QPCR Cases
n=154 n=58 P* n=67 P* n=50 P*
Gender
  Male 110 71.4% 41 70.7% 0.88 48 71.6% 0.96 36 72.0% 0.91
  Female 44 28.6% 17 29.3% 19 28.4% 14 28.0%
Ethnicity
  White 148 96.1% 57 98.3% 0.41 65 97.0% 0.69 51 98.1% 0.66
  Non-white 6 4.4% 1 4.4% 2 4.4% 1 4.4%
Age, years
  Median (Range) 58 (23–89) 61 (23–80) 0.42§ 58 (23–80) 0.76§ 60 (23–80) 0.44§
Smoking Status
  Never smoker 24 15.6% 6 10.3% 0.20 9 13.4% 0.79 6 12.0% 0.65
  Former smoker 50 32.5% 23 39.7% 23 34.3% 16 32.0%
  Active Smoker 80 51.9% 29 50.0% 35 52.2% 28 56.0%
Cigarette Pack-Years
  Never smoker 24 15.6% 6 10.3% 0.16 9 13.4% 0.42 6 12.0% 0.45
  1–59 py 57 37.0% 18 31.0% 21 31.3% 17 34.0%
  ≥60 py 58 37.7% 26 44.8% 28 41.8% 22 44.0%
  Unknown 15 9.7% 8 13.8% 9 13.4% 5 10.0%
Alcohol Drinker
  Never drinker 40 26.0% 16 27.6% 0.72 18 26.9% 0.82 14 28.0% 0.69
  Ever drinker 114 74.8% 42 74.8% 49 74.8% 36 74.8%
Alcohol Quantity
  Never drinker 40 26.0% 16 27.6% 0.85 18 26.9% 0.43 14 28.0% 0.08
  1–4 48 31.2% 16 27.6% 18 26.9% 9 18.0%
  ≥5 46 29.9% 19 32.8% 24 35.8% 20 40.0%
  Unknown 20 13.0% 7 12.1% 7 10.4% 7 14.0%
Tumor Type
  Neck Metastasis 2 1.3% 2 3.4% .15 2 3.0% .30 1 2.0% .28
  New Primary 11 7.1% 2 3.4% 3 4.5% 1 2.0%
  Primary 128 83.1% 50 86.2% 57 85.1% 43 86.0%
  Recurrence 13 8.4% 4 6.9% 5 7.5% 5 10.0%
Tumor Site
  Oral Cavity 70 45.5% 23 39.7% .32 27 40.3% .23 16 32.0% .06
  Oropharynx 29 18.8% 12 20.7% 12 17.9% 12 24.0%
  Hypopharynx 11 7.1% 2 3.4% 3 4.5% 2 4.0%
  Larynx 40 26.0% 19 32.8% 22 32.8% 18 36.0%
  Neck 4 2.6% 2 3.4% 3 4.5% 2 4.0%
Disease Stage
  I 26 16.9% 6 10.3% .09 6 9.0% .049 5 10.0% .45
  II 21 13.6% 11 19.0% 13 19.4% 7 14.0%
  III 30 19.5% 7 12.1% 10 14.9% 8 16.0%
  IV 61 39.6% 27 46.6% 30 44.8% 23 46.0%
  Recurrence/Metastasis 15 9.7% 6 10.3% 7 10.4% 6 12.0%
Unknown 1 0.6% 1 1.7% 1 1.5% 1 2.0%
Treatment
  RT Only 41 26.8% 19 32.8% .43 20 29.0% .73 18 36.0% .16
  CRT 27 17.6% 10 17.2% 11 15.9% 9 18.0%
  No CRT 79 51.6% 27 46.6% 35 50.7% 21 42.0%
  Unknown 6 3.9% 2 3.4% 3 4.3% 2 4.0%
Vital Status
  Alive 79 51.3% 26 44.8% 0.15 30 44.8% 0.12 20 40.0% 0.04
  Dead 73 47.4% 32 55.2% 37 55.2% 30 60.0%
Unknown 2 1.3% 0 0.0% 0 0.0% 0 0.0%
Time to Death, months
  Median (Range) 44.6 (1.5–112.3) 42.2 (1.5–112.3) 0.44 42.5 (1.5–112.3) 0.21 44.2 (1.5–112.3) 0.21
Disease Progression Status
  No disease progression 64 41.6% 22 37.9% 26 38.8% 16 32.0%
0.41 0.46 0.08
  Disease Progression 88 57.1% 36 62.1% 41 61.2% 34 68.0%
Unknown 2 1.3% 0 0.0% 0 0.0% 0 0.0%
Progression Free Survival, months
  Median (Range) 33.8 (1.2–108.4) 26.4 (1.2–106.9) 0.51 26.8 (1.2–106.9) 0.40 24.8 (1.2–106.9) 0.28

Typical number of alcohol drinks in 2 week period

Chi square test

§

Rank sum test

Fisher's exact test

Log rank test

*

Analyzed versus unanalyzed cases